Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 September 2021 | Story Leonie Bolleurs | Photo 3T Photography
The new US Consul General, Vincent Spera, recently visited the UFS Bloemfontein Campus. He was hosted by the Office for International Affairs. Pictured here are Cornelius Hagenmeier, Dr Dionne van Reenen, and Vincent Spera.

Vincent Spera, the new US Consul General, paid a courtesy visit to the University of the Free State (UFS) on 16 September 2021, where he was hosted by the Office for International Affairs on the Bloemfontein Campus.

The aim of his visit was to strengthen relationships with the UFS. The university has a rich academic collaboration with US higher education institutions, as evidenced by the 313 co-authored papers published by UFS authors with collaborators at 291 institutions in the United States (US) between 2018 and 2020.

In the past eight years, close to 150 international students from the US – from postdoctoral fellows up to undergraduate level – studied at the UFS. The UFS is also home to more than 30 research fellows from the US. 

Cornelius Hagenmeier, Director of the UFS Office for International Affairs, says he would like every student to have an international experience. “I believe it is doable. Through virtual exchanges, curriculum internationalisation, and internationalisation at home, we can make this happen,” he says. 

Prof Corli Witthuhn, Vice-Rector: Research, emphasised the importance of US collaborations for the university. She appreciates the support afforded by the US Consulate for the manifold collaborative activities connecting the UFS with the US. 

A number of UFS researchers who is collaborating with the US on certain projects interacted with Spera during his visit. 

USDP Programme

According to Prof Corlia Janse van Vuuren, Head: UFS School of Health and Rehabilitation Sciences, the Faculty of Health Sciences’ biggest academic collaboration with US higher education institutions is through the University Staff Development Programme (USDP).

She says: “The USDP is an enriching journey for the group of UFS academic staff members who participate as PhD candidates in this initiative. The international connection with the University of Virginia (UVA), where mentors are assigned to most of the PhD candidates, is raising the quality of the qualification.”

This doctoral training programme supports the doctoral degree studies of a cohort of six academics from the UFS and five from the University of Venda (Univen) in the field of global health. The group of PhD candidates are from different disciplines in health sciences, including Anaesthesiology, Orthopaedics, Obstetrics and Gynaecology, as well as Occupational Therapy in the Allied Health Sciences. One of the candidates completed his studies and is working with UVA on a number of publications; the rest of the candidates will complete their studies in 2022 and 2023. 

“These doctoral candidates are also very much involved in student training as well as medical specialist training. This increases the quality of our medical specialist training in the faculty. Undergraduate student training also indirectly benefits from this initiative,” she adds.

Dr Gray Magaiza, Acting Assistant Vice-Dean and Programme Director in the Department of Sociology on the UFS Qwaqwa Campus, is in agreement about the value of the USDP programme. He himself received his PhD qualification through the programme. 

US Consul General, Vincent Spera, and Prof Corli Witthuhn, , Vice-Rector: Research, Innovation and
Internationalisation. (Photo: 3T Photography)

“The programme opened many doors for me. It was one of the best experiences I ever had, especially the support I received in completing my studies. The quality sought by US supervisors are also quite high,” he says. 

Spera says it is wonderful to hear about the collaborations taking place. “It is through these partnerships that connections between South Africans and Americans are allowed to grow exponentially.”

“PhD development is critical, and we want to increase the number of PhD graduates, particularly staff members with PhD qualifications. We appreciate the collaboration with the US in research and capacity development, which together with internalisation are high priorities,” Hagenmeier says.

Fulbright Scholarships

Prof Lynette Jacobs, Head of Research on the UFS South Campus, acknowledged the contribution that the Fulbright programme has made to the UFS South Campus. Four years ago, the visit of one Fulbright scholar, Prof Barbara Howard from the Appalachian State University, evolved to a long-term commitment from individuals and the institution to continue working on intercultural and international projects, as well as research collaborations. 

Together with academics from Novgorod State University in Russia, Prof Jacobs and Prof Howard are collaborating on the development of virtual capacity building programmes, specifically to support internationalisation. The courses include international cross-cultural communication skills, leadership in virtual international teams, sustainable development, and using technology meaningfully in a virtual international space. 

“This is a wonderful testament to not letting ourselves get fixed to one kind of thinking. It does not always have to be the five-year PhD or two-year academic Fulbright programme, but there are all sorts of models that can make a difference,” responds Spera.

Guided by Dr Dionne van Reenen, Senior Researcher in the Unit for Institutional Change and Social Justice, Spera undertook a walking tour of the UFS Centenary Complex and the Unit for Institutional Change and Social Justice. He appreciated the information shared about the UFS transformation process, and the collaboration between the US and the unit. 

According to Mbali Moiketsi, Study Abroad coordinator, the US consulate has supported and offered guidance to UFS students and staff to pursue study abroad opportunities with the assistance of International Affairs. 

Recently, the university had two recipients of the Fulbright foreign student scholarship and has to date hosted three Fulbright visiting scholars. These recipients have contributed to the growth of the partnership and has increased relations with universities in the US. The partnership is set to continue, offering broad opportunities for the UFS staff and students. 

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept